Glaucoma
is the leading cause of irreversible blindness worldwide, and its prevalence
will continue to increase as our population ages. For most patients, the
initial treatment for glaucoma will begin with eye drops or laser treatment, or
even both. Patients often have a difficult time adhering to a schedule of
single or even multiple doses of eye drops and thus find an initial laser treatment
beneficial. Sometimes even with eye drops and laser treatment for glaucoma it
is not possible to lower the intraocular pressure enough to reduce the risk of
vision loss. For these patients there has been the next step of complex
incisional glaucoma surgery. Recent advances in Minimally Invasive Glaucoma
Surgery (MIGS) using microscopic stents has been shown to provide excellent
results for many glaucoma patients. Reports in the Journal of Cataract & Refractive Surgery of patients who had
iStent-a tiny titanium stent-implanted through a microscopic incision, had
excellent pressure lowering and even were able to reduce their need for eye
drops! The data shared was from a long term 5 year clinical study and offers
great promise for glaucoma patients.
The
best way to prevent vision loss from glaucoma is by having regular eye exams
and glaucoma testing as recommended by your eye doctor. If you or someone you know is concerned about their glaucoma
risk please be sure to schedule an eye exam at Northwest Indiana Eye & Laser Center at
219-464-8223, or visit Northwest Indiana
Eye & Laser Center, or facebook.com/nwindianaeyeandlaser.
Northwest Indiana Eye & Laser Center
offices are located at 502 Marquette Street, Valparaiso, Indiana 46383 and 1003
South Edgewood Drive, Knox, Indiana 46354
No comments:
Post a Comment